Detalhe da pesquisa
1.
Pharmacokinetics, Safety, and Efficacy of Glecaprevir/Pibrentasvir in Children With Chronic HCV: Part 2 of the DORA Study.
Hepatology
; 74(1): 19-27, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33811356
2.
Durability of sustained virological response to glecaprevir/pibrentasvir and resistance development: A long-term follow-up study.
Liver Int
; 42(6): 1278-1286, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35220658
3.
Efficacy and Safety of 8- or 12 Weeks of Glecaprevir/Pibrentasvir in Patients with Evidence of Portal Hypertension.
Infect Dis Ther
; 11(2): 913-924, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35174470
4.
Long-Term Efficacy and Safety of Risankizumab in Patients with Active Psoriatic Arthritis: Results from a 76-Week Phase 2 Randomized Trial.
Rheumatol Ther
; 9(5): 1361-1375, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35931879